Please wait while the formulary information is being retrieved.
WHYTEDERM SURGIPAK (MUPIROCIN/CHLORHEXIDINE GLUCONATE/DIMETH/SILICONE, ADHESIVE)
2 %-4 %-2 % topical kit
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Large open wound
Severe
Moderate
- No disease contraindications
WHYTEDERM SURGIPAK (MUPIROCIN/CHLORHEXIDINE GLUCONATE/DIMETH/SILICONE, ADHESIVE)
- None
- Headache disorder
- Nausea
- Skin rash
More Frequent
Severe
Less Severe
- None
- Dry skin
- Erythema
- Pruritus of skin
- Skin inflammation
- Skin swelling
- Stinging of skin
- Treatment site sequelae
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Angioedema
- Clostridium difficile infection
- Dyspnea
- Facial edema
- Hypotension
- Tachycardia
- Urticaria
- Wheezing
Less Severe
- Acute abdominal pain
- Aphthous stomatitis
- Contact dermatitis
- Dizziness
- Erythema
- Pain
- Skin irritation
- Skin rash
- Urticaria
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Mupirocin (Topical)
Not recommended in infants less than 3 months
- 1 Day – 89 Days
- Not recommended in infants less than 3 months
Mupirocin
- Severity Level:
2
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Mupirocin
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
Chlorhexidine
Insufficient data available;Poor oral absorption
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Insufficient data available;Poor oral absorption |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool